Although it is known that calcitonin (CT) is a pharmacological inhibitor of bone resorption and calcitonin gene-related product (CGRP) is a potent vasodilator and neuropeptide, the physiologic role for these related peptides remains unproved. The CALC I and CALC II genes encode for CGRP. Transcription of CALC I results in an mRNA coding for both CT and CGRP-I. CALC II produces only CGRP (CGRP-II). The two CGRP peptides are highly homologous with unique, at times overlapping, tissue distributions. To dissect the contributions of these closely related hormones to normal mammalian development and physiology, animal models containing null mutations at each locus will be generated. To accomplish this, each gene will be selectively eliminated using the technique of targeted gene disruption in pluripotent mouse embryonic stem (ES) cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08DK002274-01A1
Application #
2134135
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1995-01-30
Project End
1995-10-31
Budget Start
1995-01-30
Budget End
1995-10-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030